{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T01:42:15Z","timestamp":1775958135793,"version":"3.50.1"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>The majority children living with HIV infection now survive into adulthood because of effective antiretroviral therapy (ART), but few data exist on their growth during adolescent years. This study investigated growth patterns and evaluated factors associated with suboptimal growth in adolescents with perinatally-acquired HIV infection.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>This retrospective cohort study included HIV-infected adolescents, aged 13 to 18 years, with at least 5 years of ART follow-up at a large HIV clinic in the Gauteng Province, South Africa. Weight-for-age Z-scores (WAZ), height-for-age Z-scores (HAZ) and body mass index (BMI)-for-age Z-scores were calculated using World Health Organization (WHO) growth standards. Growth velocity graphs were generated utilising the mean height change calculated at 6-monthly intervals, using all available data after ART initiation, to calculate the annual change. Other collected data included WHO HIV disease staging, CD4%, HIV viral loads (VLs), ART regimens and tuberculosis co-infection.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>Included were 288 children with a median age of 6.5 years (IQR 4.2;8.6 years) at ART initiation, and 51.7% were male. At baseline the majority of children had severe disease (92% WHO stages 3&amp;4) and were started on non-nucleoside reverse transcriptase inhibitor-based regimens (79.2%). The median CD4% was 13.5% (IQR 7.9;18.9) and median HIV viral load log 5.0 (IQR 4.4;5.5). Baseline stunting (HAZ &lt;-2) was prevalent (55.9%), with a median HAZ of -2.2 (IQR -3.1;-1.3). The median WAZ was -1.5 (IQR -2.5;-0.8), with 29.2% being underweight-for-age (WAZ &lt;-2). The peak height velocity (PHV) in adolescents with baseline stage 3 disease was higher than for those with stage 4 disease. Being older at ART start (p&lt;0.001) and baseline stunting (p&lt;0.001) were associated with poorer growth, resulting in a lower HAZ at study exit, with boys more significantly affected than girls (p&lt;0.001).<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusions<\/jats:title><jats:p>Suboptimal growth in adolescents with perinatally-acquired HIV infection is a significant health concern, especially in children who started ART later in terms of age and who had baseline stunting and is more pronounced in boys than in girls.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0262816","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T18:33:31Z","timestamp":1643135611000},"page":"e0262816","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Growth and the pubertal growth spurt in South African adolescents living with perinatally-acquired HIV infection"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2242-087X","authenticated-orcid":true,"given":"Bilema","family":"Mwambenu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vundli","family":"Ramoloko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ria","family":"Laubscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6339-1040","authenticated-orcid":true,"given":"Ute","family":"Feucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"pone.0262816.ref001","unstructured":"World Health Organization (July 2019). Treat all: policy adoption and implementation status in countries. https:\/\/www.who.int\/hiv\/pub\/arv\/treat-all-uptake\/en\/."},{"issue":"12","key":"pone.0262816.ref002","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7196\/SAMJ.9110","article-title":"Focus on adolescents with HIV and AIDS","volume":"104","author":"L Fairlie","year":"2014","journal-title":"S. Afr. Med. J"},{"issue":"1","key":"pone.0262816.ref003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QAI.0b013e3181b9869f","article-title":"Declines in mortality rates and changes in causes of death in HIV-infected children during the HAART era","volume":"53","author":"Pediatric AIDS Clinical Trials Group219\/219C Team","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0262816.ref004","unstructured":"UNAIDS (2019). Community at the centre: Global AIDS Update. https:\/\/www.unaids.org\/en."},{"key":"pone.0262816.ref005","unstructured":"UNICEF data. HIV and AIDS in adolescents, July 2019. https:\/\/data.unicef.org\/topic\/adolescents\/hiv-aids\/."},{"issue":"11","key":"pone.0262816.ref006","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7196\/SAMJ.2015.v105i11.10130","article-title":"Adolescents HIV treatment issues in South Africa","volume":"105","author":"H. Daood","year":"2015","journal-title":"S. Afr. Med. J"},{"issue":"10","key":"pone.0262816.ref007","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00002030-200307040-00003","article-title":"Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral-treated HIV-infected adolescents","volume":"17","author":"A Vigano","year":"2003","journal-title":"J. Int. AIDS Soc"},{"issue":"3","key":"pone.0262816.ref008","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/COH.0000000000000450","article-title":"Growth and pubertal development in HIV-infected adolescents","volume":"13","author":"PL Williams","year":"2018","journal-title":"Curr Opin HIV AIDS"},{"issue":"12","key":"pone.0262816.ref009","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/QAD.0b013e328361195b","article-title":"Pubertal onset in HIV-infected Children in the era of combined antiretroviral treatment","volume":"27","author":"PL Williams","year":"2013","journal-title":"AIDS"},{"issue":"0","key":"pone.0262816.ref010","first-page":"639","article-title":"Growth patterns in pubertal HIV-infected adolescents and their correlation with cytokines, IGF-1, IGFBP-1, and IGFBP-3","volume":"26","author":"M Kessler","year":"2013","journal-title":"J Pediat endocrinol metab"},{"issue":"11","key":"pone.0262816.ref011","doi-asserted-by":"crossref","first-page":"e25412","DOI":"10.1002\/jia2.25412","article-title":"Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration","volume":"22","author":"J Jesson","year":"2019","journal-title":"J. Int AIDS Soc"},{"issue":"5","key":"pone.0262816.ref012","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.medmal.2015.03.002","article-title":"Challenges of malnutrition care among HIV-infected children on antiretroviral treatment in Africa","volume":"45","author":"J Jesson","year":"2015","journal-title":"Med Mal Infect"},{"issue":"5","key":"pone.0262816.ref013","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/tmi.12685","article-title":"Growth in HIV-infected children on long-term antiretroviral therapy","volume":"21","author":"UD Feucht","year":"2016","journal-title":"Trop Med Int Health"},{"key":"pone.0262816.ref014","unstructured":"WHO case definition of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. World Health Organization 2007. https:\/\/apps.who.int\/iris\/handle\/10665\/43699."},{"key":"pone.0262816.ref015","unstructured":"National consolidated guidelines for the prevention of mother-to-child transmission of HIV(PMTCT) and the management of HIV in children, adolescents and adults. National Department of Health, South Africa. 2019 October. http:\/\/www.health.gov.za\/."},{"issue":"9","key":"pone.0262816.ref016","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a World Health Organization growth reference for school-aged children and adolescents","volume":"85","author":"M De Onis","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"1","key":"pone.0262816.ref017","doi-asserted-by":"crossref","first-page":"1626184","DOI":"10.1080\/16549716.2019.1626184","article-title":"The effect of childhood stunting and wasting on adolescents cardiovascular disease risk and educational achievement in rural Uganda: a retrospective cohort study","volume":"12","author":"G Asiki","year":"2019","journal-title":"Global health Action"},{"issue":"2","key":"pone.0262816.ref018","first-page":"75","article-title":"The effect of early childhood stunting on children\u2019s cognitive achievements: Evidence from young lives","volume":"31","author":"T Woldehanna","year":"2017","journal-title":"Ethiopia. Ethiop J Health Dev"},{"issue":"6","key":"pone.0262816.ref019","doi-asserted-by":"crossref","first-page":"e20163177","DOI":"10.1542\/peds.2016-3177","article-title":"Adult consequences of self-limited delayed puberty","volume":"139","author":"J Zhu","year":"2017","journal-title":"Pediatrics"},{"issue":"12","key":"pone.0262816.ref020","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0000000000002294","article-title":"Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand","volume":"33","author":"The European Pregnancy Paediatric HIV Cohort Collaboration (EPPICC) study group","year":"2019","journal-title":"AIDS"},{"issue":"5","key":"pone.0262816.ref021","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/QAD.0000000000000590","article-title":"Pubertal development in HIV-infected African children on first-line antiretroviral therapy","volume":"29","author":"AJ Szubert","year":"2015","journal-title":"AIDS"},{"issue":"6","key":"pone.0262816.ref022","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/tropej\/fmm060","article-title":"Reasons for the delay in initiation of antiretroviral therapy in a population of HIV infected South African children","volume":"53","author":"UD Feucht","year":"2007","journal-title":"J Trop Pediatr"},{"issue":"1","key":"pone.0262816.ref023","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13104-019-4279-z","article-title":"Late antiretroviral therapy initiation and associated factors among children on antiretroviral therapy at University of Gondar Comprehensive Specialised Hospital, Gondar, North west Ethiopia: A cross sectional study","volume":"12","author":"GM Belay","year":"2019","journal-title":"BMC Res Notes"},{"key":"pone.0262816.ref024","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fped.2019.00159","article-title":"Tuberculosis and HIV\u2014An Update on the \u201ccursed duet\u201d in children","volume":"7","author":"SH Fry","year":"2019","journal-title":"Front Pediatr"},{"key":"pone.0262816.ref025","doi-asserted-by":"crossref","unstructured":"Sashindran VK, Thakur R. Malnutrition in HIV\/AIDS: etiopathogenesis. Feb 2020 https:\/\/www.intechopen.com\/books\/nutrition-and-hiv-aids-implication-for-treatment-prevention-and-cure\/malnutrition-in-hiv-aids-aetiopathogenesis.","DOI":"10.5772\/intechopen.90477"},{"issue":"2","key":"pone.0262816.ref026","doi-asserted-by":"crossref","first-page":"097","DOI":"10.1055\/s-0035-1556974","article-title":"Antiretroviral therapy for HIV-infected adolescents in Uganda: Assessing the impact of growth and sexual maturation","volume":"3","author":"S Bakeera-Kitaka","year":"2015","journal-title":"J Pediatr Infect Dis"},{"issue":"2","key":"pone.0262816.ref027","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/INF.0000000000000961","article-title":"TREAT Asia Pediatric HIV observational Database. Final height and associated factors in perinatal HIV-infected Asian adolescents","volume":"35","author":"T Bunupuradah","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"pone.0262816.ref028","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1186\/s12889-018-6048-7","article-title":"\u201cHow am I going to live?\u201d: Exploring barriers to ART adherence among adolescents and young adults living with HIV in Uganda","volume":"18","author":"S MacCarthy","year":"2018","journal-title":"BMC Public Health"},{"issue":"10","key":"pone.0262816.ref029","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/INF.0000000000000801","article-title":"Growth in Virologically Suppressed HIV Positive Children on Antiretroviral Therapy: Individual and Population-level References","volume":"34","author":"O Keiser","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"pone.0262816.ref030","doi-asserted-by":"crossref","first-page":"20049","DOI":"10.7448\/IAS.18.1.20049","article-title":"Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: A narrative review","volume":"18","author":"OA Adejuno","year":"2015","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"pone.0262816.ref031","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/09540121.2015.1011073","article-title":"Factors associated with adherence to antiretroviral therapy among adolescents living with HIV\/AIDS in low-and middle-income countries: A systematic review","volume":"27","author":"C Hedelson","year":"2015","journal-title":"AIDS care"},{"key":"pone.0262816.ref032","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12879-015-1265-5","article-title":"Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda","volume":"15","author":"N Nabukeera-Barungi","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0262816.ref033","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1186\/s12889-018-6048-7","article-title":"How am I going to live?\u201d: Exploring barriers to ART adherence among adolescents and young adults living with HIV in Uganda","volume":"18","author":"S MacCarthy","year":"2018","journal-title":"BMC Public Health"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0306221","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0262816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T07:56:47Z","timestamp":1700121407000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0262816"}},"subtitle":[],"editor":[{"given":"Evy","family":"Yunihastuti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0262816","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0306221","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]}}}